Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis
Journal of the International AIDS Society · 2024
DOI: 10.1002/jia2.26265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, 2024. Verfasst von Benjamin Enns und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: HIV Infections, Cost-Benefit Analysis, Pre-Exposure Prophylaxis, Homosexuality, Male. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institutes on Drug Abuse.
Abstract (Originalsprache)
Introduction
Improving the delivery of existing evidence‐based interventions to prevent and diagnose HIV is key to Ending the HIV Epidemic in the United States. Structural barriers in the access and delivery of related health services require municipal or state‐level policy changes; however, suboptimal implementation can be addressed directly through interventions designed to improve the reach, effectiveness, adoption or maintenance of available interventions. Our objective was to estimate the cost‐effectiveness and potential epidemiological impact of six real‐world implementation interventions designed to address these barriers and increase the scale of delivery of interventions for HIV testing and pre‐exposure prophylaxis (PrEP) in three US metropolitan areas.
Methods
We used a dynamic HIV transmission model calibrated to replicate HIV microepidemics in Atlanta, Los Angeles (LA) and Miami. We identified six implementation interventions designed to improve HIV testing uptake (“Academic detailing for HIV testing,” “CyBER/testing,” “All About Me”) and PrEP uptake/persistence (“Project SLIP,” “PrEPmate,” “PrEP patient navigation”). Our comparator scenario reflected a scale‐up of interventions with no additional efforts to mitigate implementation and structural barriers. We accounted for potential heterogeneity in population‐level effectiveness across jurisdictions. We sustained implementation interventions over a 10‐year period and evaluated HIV acquisitions averted, costs, quality‐adjusted life years and incremental cost‐effectiveness ratios over a 20‐year time horizon (2023–2042).
Results
Across jurisdictions, implementation interventions to improve the scale of HIV testing were most cost‐effective in Atlanta and LA (CyBER/testing cost‐saving and All About Me cost‐effective), while interventions for PrEP were most cost‐effective in Miami (two of three were cost‐saving). We estimated that the most impactful HIV testing intervention, CyBER/testing, was projected to avert 111 (95% credible interval: 110–111), 230 (228–233) and 101 (101–103) acquisitions over 20 years in Atlanta, LA and Miami, respectively. The most impactful implementation intervention to improve PrEP engagement, PrEPmate, averted an estimated 936 (929–943), 860 (853–867) and 2152 (2127–2178) acquisitions over 20 years, in Atlanta, LA and Miami, respectively.
Conclusions
Our results highlight the potential impact of interventions to enhance the implementation of existing evidence‐based interventions for the prevention and diagnosis of HIV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.
- School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
- Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
- School of Social Work, Columbia University, New York, New York, USA.
- Center for Dissemination and Implementation, Institute for Public Health, Division of Infectious Diseases, Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
ORCID-Profile: Susanne Doblecki-Lewis, Elvin H Geng, Albert Y Liu, Brandon D L Marshall, Patrick S Sullivan, Bohdan Nosyk
Förderung
- NIDA NIH HHS
- National Institutes on Drug Abuse
Zitieren
APA
Enns, B., Sui, Y., Guerra-Alejos, B. C., Humphrey, L., Piske, M., Zang, X., Doblecki-Lewis, S., Feaster, D. J., Frye, V. A., Geng, E. H., Liu, A. Y., Marshall, B. D. L., Rhodes, S. D., Sullivan, P. S., Nosyk, B., & localized economic modelling study group (2024). Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26265
Vancouver
Enns B, Sui Y, Guerra-Alejos BC, Humphrey L, Piske M, Zang X, et al. Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis. Journal of the International AIDS Society. 2024. doi:10.1002/jia2.26265
BibTeX
@article{Enns2024,
author = {Enns, Benjamin and Sui, Yi and Guerra-Alejos, Brenda C and Humphrey, Lia and Piske, Micah and Zang, Xiao and Doblecki-Lewis, Susanne and Feaster, Daniel J and Frye, Victoria A and Geng, Elvin H and Liu, Albert Y and Marshall, Brandon D L and Rhodes, Scott D and Sullivan, Patrick S and Nosyk, Bohdan and localized economic modelling study group, localized economic modelling study group},
title = {Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis},
journal = {Journal of the International AIDS Society},
year = {2024},
doi = {10.1002/jia2.26265}
}
EUVIMED